Like hapless Jeopardy contestants, Washington policymakers know the answer to many constituents’ misery is to prevent drug shortages, but they are struggling to find the right question.
Is it how to get market intermediaries to take less profit? Is it how to get pharmaceutical companies to manufacture drugs at a loss